MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Optimizing the Engineering Design of Ambulatory Care Facilities
Designing cost-effective engineering systems is not about minimizing investment but about investing strategically.
Construction Completed on Washington Health Urgent Care Facility in California
The design team maximized the existing footprint to accommodate five exam rooms, a dedicated procedure room and an X-ray room.
OhioHealth Pickerington Methodist Hospital Begins Expansion Project
It includes an expansion of the emergency department (ED) and an additional inpatient unit.
IAQ and Infection Mitigation: Plans Into Actions
To support quality patient care and ensure compliance, managers must stay ahead of environmental and IAQ risks.
Case Study: How NYU Langone Rebuilt for Resilience After Superstorm Sandy
Although the damage was severe, it provided a valuable opportunity for NYU Langone to assess structural vulnerabilities and increase facility resilience.